RPTOR and follicular lymphoma: WES previously revealed recurrent mTORC1‐activating mutations in RRAGC, which encodes RagC, in follicular lymphoma; the mutants increased raptor binding while rendering mTORC1 signaling resistant to amino acid deprivation.63